Novo Nordisk Tries to Snatch a Weight-Loss Biotech From Pfizer. There Are Political Risks. Denmark’s Novo offers $56.50 a share in cash for Metsera, plus potentially a further $21.25 a share based on ...
The greater part of third quarter earnings results are in the rearview mirror, though investors this week are looking to reports from The Walt Disney Company and Alibaba . So far, ...
2dOpinion
What Is Happening With Roblox Stock?
Roblox (RBLX)’s stock has soared nearly 92% over the past year, fueled not only by accelerating revenue but also by renewed ...
The greater part of third quarter earnings results are in the rearview mirror, though investors this week are looking to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback